SCHEMBL3242401

SCHEMBL3242401

O=P(O)(O)Cc1nc(Cl)cc(N2CCCC2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
LMNA P02545 2/20 0.35
KMT2A Q03164 3/20 0.35
CASP1 P29466 4/20 0.34
CASP5 P51878 4/20 0.34
CASP4 P49662 3/20 0.34
RAF1 P04049 1/20 0.34
BRAF P15056 1/20 0.34
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
CHRM3 P20309 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
GBA1 P04062 2/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2020520 0.80 KMT2A (0.38) CYP1A2CYP2D6MAPTLMNAKMT2A
SCHEMBL2027503 0.80 SORD (0.45) CYP1A2CYP2D6MAPTLMNAKMT2A
SCHEMBL2021947 0.79 CYP1A2 (0.44) CYP1A2CYP2D6MAPTKMT2ACASP1
SCHEMBL3231825 0.79 PGK1 (0.42) SMN1; SMN2
SCHEMBL2021817 0.76 LMNA (0.41) CYP1A2CYP2D6MAPTLMNAKMT2A
SCHEMBL21157766 0.75 CRHBP (0.42) CYP1A2CYP2D6MAPTKMT2ACASP1
SCHEMBL3233648 0.72 CHRM3 (0.47) HRH4CHRM3PDE4APDE4BPDE4C
SCHEMBL2020522 0.71 KMT2A (0.36) CYP1A2CYP2D6MAPTLMNAKMT2A
SCHEMBL3236763 0.69 CYP1A2 (0.48) CYP1A2CYP2D6MAPTLMNAKMT2A
SCHEMBL2772556 0.69 CASP1 (0.61) CYP1A2CYP2D6MAPTKMT2ACASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010027097-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-11 WO disclosed